Le Lézard
Classified in: Health
Subjects: MAV, FVT, CPG, CFG

/R E P E A T -- Notice to the media - The Governments of Canada and Yukon will announce new measures to increase access to treatment for substance use disorder/


WHITEHORSE, Dec. 14, 2018 /CNW/ - On behalf of the Honourable Ginette Petitpas Taylor, federal Minister of Health, the Honourable Larry Bagnell, Member of Parliament, and the Honourable Pauline Frost, Minister of Health and Social Services, Yukon, will announce new measures to increase access to treatment for substance use disorder.

MP Bagnell and Minister Frost will be available to answer questions from the media following the announcement.

Date
December 17, 2018

Time
10:00 am PST

Location
Media room
(Located inside the Old Library)
Main Administration Building
Government of Yukon
2703, 2nd Avenue
Whitehorse, Yukon Y1A 1C9

 

SOURCE Health Canada


These press releases may also interest you

at 16:45
Mahesh Krishnan Elected to Halozyme's Board of Directors
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:35
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands Celebrates Big Wins at the Craft Brewer's Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...

at 16:28
American Business Awards: Dr. Siva Mohan, CMO of RazorMetrics
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...

More news about Health...


News published on and distributed by: